Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T)
Author:
Affiliation:
1. Department of Cardiovascular Diseases, Fukuoka University Chikushi Hospital, Chikushino, Japan
2. Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Japan
Funder
Tanabe Mitsubishi Pharma Corporation
Publisher
Informa UK Limited
Subject
General Medicine,Physiology,Internal Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/10641963.2019.1601207
Reference19 articles.
1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
2. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
3. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
4. Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial;Perspectives in Clinical Research;2024-07-10
2. Dermatological side effects of dipeptidyl Peptidase-4 inhibitors in diabetes management: a comprehensive review;Clinical Diabetes and Endocrinology;2024-03-25
3. Evaluation of Neural Network-Based Derivatives for Topology Optimization;Journal of Mechanical Design;2024-01-29
4. Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study;Expert Review of Endocrinology & Metabolism;2023-05-26
5. Analysis on application effect and prognostic factors of medical care combined with nursing in the elderly with T2DM and Cerebral Infarction based on targeted management mode;Biotechnology and Genetic Engineering Reviews;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3